Cargando…
The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78
In contrast to other haematological malignancies, targeted immunotherapy has not entered standard treatment regimens for de novo or relapsed multiple myeloma (MM) yet. While a number of IgG-formatted monoclonal antibodies are currently being evaluated in clinical trials in MM, our study aimed to inv...
Autores principales: | Rasche, Leo, Duell, Johannes, Morgner, Charlotte, Chatterjee, Manik, Hensel, Frank, Rosenwald, Andreas, Einsele, Hermann, Topp, Max S., Brändlein, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646784/ https://www.ncbi.nlm.nih.gov/pubmed/23667612 http://dx.doi.org/10.1371/journal.pone.0063414 |
Ejemplares similares
-
Simultaneous Binding of the Anti-Cancer IgM Monoclonal Antibody PAT-SM6 to Low Density Lipoproteins and GRP78
por: Rosenes, Zachary, et al.
Publicado: (2013) -
The Anti-Cancer IgM Monoclonal Antibody PAT-SM6 Binds with High Avidity to the Unfolded Protein Response Regulator GRP78
por: Rosenes, Zachary, et al.
Publicado: (2012) -
Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1
por: HENSEL, FRANK, et al.
Publicado: (2014) -
Expression and release of glucose-regulated protein-78 (GRP78) in multiple myeloma
por: Steiner, Normann, et al.
Publicado: (2017) -
The Endogenous GRP78 Interactome in Human Head and Neck Cancers: A Deterministic Role of Cell Surface GRP78 in Cancer Stemness
por: Chen, Hsin-Ying, et al.
Publicado: (2018)